[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
Article
June 1996

Improved Graft Survival in Cadaveric Renal Retransplantation by Flow Crossmatching

Author Affiliations

From the Midwest Organ Bank Inc, Westwood, Kan (Drs Nelson and Bryan and Ms Eschliman); St Francis Medical Center, Wichita, Kan (Dr Shield); Research Medical Center, Kansas City, Mo (Dr Aeder); the Department of Pathology, University of Missouri-Columbia (Dr Luger); the Departments of Surgery, the University of Missouri-Kansas City (Dr Nelson) and the University of Kansas Medical Center, Kansas City (Dr Pierce).

Arch Surg. 1996;131(6):599-603. doi:10.1001/archsurg.1996.01430180025004
Abstract

Objective:  To evaluate the role of flow cytometry crossmatching on graft survival in patients undergoing cadaveric renal retransplantation compared with our conventional antihuman globulin cytotoxic crossmatch.

Design:  In 1990, 6 of 7 transplantation centers in 1 organ procurement organization service area began performing cadaveric renal retransplantation only if the flow T-cell IgG crossmatch was negative. During that period, 1 center continued to use only the antihuman globulin T-cell IgG crossmatch. Prior to 1990, all centers used only the antihuman globulin T-cell IgG crossmatch as their crossmatch selection criterion for retransplantation. Regraft survival was compared between those centers by crossmatch selection criteria.

Patients:  Patient selection and immunosuppression decisions were made at the transplantation center.

Setting:  All flow cytometry crossmatches for all 7 centers participating in the evaluation were performed at the Histocompatibility Laboratory of the Midwest Organ Bank Inc, Westwood, Kan.

Results:  Graft survival is significantly better (P=.03 [logrank test]) in regrafts when the flow crossmatch is used to select patients for transplantation.

Conclusion:  Flow crossmatching improves graft survival in cadaveric renal retransplantation by identifying a subset of patients with donor-directed HLA class I antibodies that are not detectable by our conventional antihuman globulin crossmatch.(Arch Surg. 1996;131:599-603)

×